Back to search
Resectable Sarcoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Resectable Sarcoma trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Resectable Sarcoma trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The aim of the study is to collect prospective data on the treatment outcomes in patients with first localized, resectable recurrent retroperitoneal well-differ…
This study will investigate the tumor-associated vasculature of patients with solid tumors. The investigators will use a technology known as intravital microsco…
The goal of this clinical research study is to look at the effectiveness of giving a combination of chemotherapy, immunotherapy, radiation therapy, and surgery…
This will be a phase II, single arm study of osteosarcoma patients with fully resected pulmonary metastases. The MTD corresponds to the dosage recommendations o…
This phase I/II trial studies the side effects of pulmonary suffusion in controlling minimal residual disease in patients with sarcoma or colorectal carcinoma t…
This study is being done to collect tissue samples to test how accurately a tumor response platform, Elephas, can predict clinical response across multiple type…
This clinical trial compares the effect of short-course ultrahypofractionated radiation therapy over 5 days (UHRT-5) to standard-course radiation therapy over 2…
Multicenter, prospective, open-labeled, 2-arm, non-comparative randomized phase II trial to assess the antitumor activity of retifanlimab (INCMGA00012) in assoc…